Durable Remission in Recurrent T-Cell—Rich B-Cell Lymphoma with the Anti-CD20 Antibody Rituximab is a research paper published in Clinical Lymphoma (2001). On theSindex it has a DataRank of 0.472. It has been cited 5 times, with 2 citing works in its 1-hop citation network.
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
Base Score Contribution
0.269
From this paper's citation signal
Citation Network Contribution
0.204
From 2 citing papers with measurable signal
DataRank blends this paper's own citation count with the influence of the papers that cite it. Here, roughly 57% comes from its base citations and 43% from the citation network (2 citing papers contributed measurable signal).
Citers are pulled from OpenAlex sorted by cited_by_count:descand capped per paper, so when the cap binds we keep the highest-signal references and the score is reproducible across reruns.
Click a node to highlight its connections. Use scroll to zoom. Drag to pan.